ICORG is a partner in the EU FP7 funded Angiopredict initiative (http://www.angiopredict.com) led by the Royal College of Surgeons in Ireland, andis responsible for the coordination of all clinical aspects of the ANGIOPREDICT study and establishment of the ANGIOPREDICT Bioresource. Biological samples collected through the prospective trial and retrospective samples made available by consortium members are stored in the ANGIOPREDICT Bioresource, which is based at the University Hospital Mannheim in Germany.
ICORG developed the ANGIOPREDICT study protocol and Standard Operating Procedures (SOP) for sample collection together with the two Chief Investigators; Prof. Matthias Ebert from the University Hospital Mannheim, Germany, and Prof Seamus O’Reilly from Cork University Hospital, Ireland.
ICORG in collaboration with the Mannheimer Arbeitsgruppe Gastrointestinale Tumoren (MARGIT) act as sponsor for the prospective trial in Germany and oversees the smooth running of the trial. Clinical data are collected using an electronic data capture (EDC) tool developed and tailored by ICORG Data Management.
Click here to visit the ANGIOPREDICT website.
For information on the ANGIOPREDICT study, please click here.